Treatments:HIV
From Proteopedia
(Difference between revisions)
Line 39: | Line 39: | ||
* [[Emtricitabine]]/[[tenofovir]], brand name [[Truvada]] | * [[Emtricitabine]]/[[tenofovir]], brand name [[Truvada]] | ||
* [[emtricitabine]]/[[tenofovir]]/[[efavirenz]], brand name [[Atripla]] | * [[emtricitabine]]/[[tenofovir]]/[[efavirenz]], brand name [[Atripla]] | ||
- | * [[Bictegravir]]/[[emtricitabine]]/tenofovir alafenamide, brand name [[Biktarvy]] | + | * [[Bictegravir]]/[[emtricitabine]]/tenofovir alafenamide, brand name [[Biktarvy]] |
+ | * [[Elvitegravir]]/[[cobicistat]]/[[emtricitabine]]/[[Tenofovir disoproxil]], brand name [[Genvoya]] | ||
</td> | </td> | ||
</tr> | </tr> |
Revision as of 13:40, 8 October 2023
Chemokine Receptor Type 5 (CCR5) Inhibitors
HIV-Protease Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Nucleoside Analog Reverse Transcriptase Inhibitors
Retroviral Integrase Inhibitors
Combinations
|